Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

BACKGROUND: Using data from the COHERE collaboration, we investigated whether primary prophylaxis for pneumocystis pneumonia (PcP) might be withheld in all patients on antiretroviral therapy (ART) with suppressed plasma human immunodeficiency virus (HIV) RNA (≤400 copies/mL), irrespective of CD4 cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkinson, Andrew, Zwahlen, Marcel, Barger, Diana, d’Arminio Monforte, Antonella, De Wit, Stephane, Ghosn, Jade, Girardi, Enrico, Svedhem, Veronica, Morlat, Philippe, Mussini, Cristina, Noguera-Julian, Antoni, Stephan, Christoph, Touloumi, Giota, Kirk, Ole, Mocroft, Amanda, Reiss, Peter, Miro, Jose M, Carpenter, James R, Furrer, Hansjakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516510/
https://www.ncbi.nlm.nih.gov/pubmed/32448894
http://dx.doi.org/10.1093/cid/ciaa615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516510/
https://www.ncbi.nlm.nih.gov/pubmed/32448894
http://dx.doi.org/10.1093/cid/ciaa615

Ejemplares similares